Melanoma Research (@melanomarealli) 's Twitter Profile
Melanoma Research

@melanomarealli

The Melanoma Research Alliance works to accelerate the pace of scientific discovery & translation. 100% of your donation goes to world-class melanoma research.

ID: 34941915

linkhttp://www.curemelanoma.org calendar_today24-04-2009 14:43:17

22,22K Tweet

14,14K Followers

4,4K Following

Cleveland Clinic MD (@cleclinicmd) 's Twitter Profile Photo

In a recent study, up to 15% of patients who received melanoma diagnoses carried mutations in cancer susceptibility genes: cle.clinic/4bgWuZR

richard white (@whitefishlab) 's Twitter Profile Photo

The Society For Melanoma Research meeting is coming up - New Orleans in October is a good place to be, with an excellent lineup of speakers. Registrations still available: smrcongress.org

The <a href="/SocietyMelanoma/">Society For Melanoma Research</a> meeting is coming up - New Orleans in October is a good place to be, with an excellent lineup of speakers. Registrations still available: smrcongress.org
Melanoma Research (@melanomarealli) 's Twitter Profile Photo

MRA was honored to attend The Wayne Stinchcomb Big Orange Foundation's 15th Annual Bull Roast in Baltimore this past weekend where we all came together to celebrate Wayne Stinchcomb's memory and continue his legacy by raising funds for melanoma research. THANK YOU to all

MRA was honored to attend The Wayne Stinchcomb Big Orange Foundation's 15th Annual Bull Roast in Baltimore this past weekend where we all came together to celebrate Wayne Stinchcomb's memory and continue his legacy by raising funds for melanoma research.

THANK YOU to all
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Join Moffitt’s Nikhil Khushalani, MD (Nikhil Khushalani) tomorrow at #ESMO24 for a discussion on the first in-human study of 225Ac-MTI-201 as a novel therapy for metastatic uveal #melanoma during the poster session. ⏰: 9/14 12 p.m. CEST 📍: Hall 6 Learn more ➡️

Join Moffitt’s Nikhil Khushalani, MD (<a href="/DrKhushalani/">Nikhil Khushalani</a>) tomorrow at #ESMO24  for a discussion on the first in-human study of 225Ac-MTI-201 as a novel therapy for metastatic uveal #melanoma during the poster session.

⏰: 9/14 12 p.m. CEST
📍: Hall 6
Learn more ➡️
Melanoma Research (@melanomarealli) 's Twitter Profile Photo

Collectively, these papers provide mechanistic insight into how PD1 and LAG3 function alone and in combination and highlight opportunities for further clinical development.

Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

At #ESMO24, Nikhil Khushalani, MD (Nikhil Khushalani) is presenting the preliminary results of a novel therapy for metastatic uveal melanoma. Read more: bit.ly/4e2DOzi ESMO - Eur. Oncology #CancerResearch

OncoAlert (@oncoalert) 's Twitter Profile Photo

As part of our partnership with American Cancer Society 🇺🇸Journals, OncoAlert 🚨Proudly presents CANCER Section Editor Jason Luke, MD, FACP who presented presents original research during the #melanoma mini oral session at #ESMO24 Revisit his article cowritten with Adnan Khattak on the

NEJM (@nejm) 's Twitter Profile Photo

Original Article: Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma (CheckMate 067) nej.md/4dUqm0g #ESMO24 | ESMO - Eur. Oncology

Original Article: Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma (CheckMate 067) nej.md/4dUqm0g 

#ESMO24 | <a href="/myESMO/">ESMO - Eur. Oncology</a>
Tatiana Prowell, MD (@tmprowell) 's Twitter Profile Photo

This is almost beyond imagination. During my oncology fellowship, ppl w/ newly diagnosed metastatic #melanoma lived ~ 6m on avg. Now we have many ppl alive AND cancer-free a decade later. We aren’t done yet, but #ScienceWillWin. Bet. 💪🏆 #OncTwitter #melsm #HistoryofMedicine

Mayo Clinic (@mayoclinic) 's Twitter Profile Photo

Approximately 100,000 people in the U.S. will be diagnosed with melanoma this year, according to the American Cancer Society. A new treatment for advanced melanoma is called tumor-infiltrating lymphocyte therapy (TIL therapy). Learn more: mayocl.in/4eqs1dL

Melanoma Research (@melanomarealli) 's Twitter Profile Photo

"At the time of my diagnosis, I was a fairly young woman, and, frankly, didn’t feel comfortable pushing my doctor harder. After the diagnosis, I was really frustrated and upset. That’s when I started to realize I needed to be proactive in all aspects of my health, including who I